Intel's valuation gap widens as the stock outruns analyst targets

Short interest, by contrast, is a secondary story here. At 3.1% of the free float, it is not crowded. The short position has grown roughly 7% over the past week — from about 134 million shares to 146 million — following the price surge, which likely reflects fresh shorts being added into the strength rather than any existential bearish thesis. Borrow costs remain negligible at 0.45%, and availability is extremely loose. The lending market is not signalling any squeeze pressure; the borrow pool is more than wide open relative to the shorts in the market. The ORTEX short score of 31 sits near the middle of the range — no alarm.

The institutional picture adds a layer of context. BlackRock added 34 million shares in its most recently reported period, lifting its stake to 8.6% of the company. Capital Research and Management added more than 42 million shares. These are meaningful flows into a name that was deeply out of favour for several years. The foundry transformation thesis — Intel rebuilding itself around external manufacturing revenue — is clearly attracting long-term allocators who had stayed away through the restructuring pain. The factor scores on EPS momentum reflect this pivot: the 30-day and 90-day EPS momentum ranks are both in the 99th and 98th percentile respectively, meaning Intel's forward estimates have moved more sharply than almost any other stock in the universe over the past quarter.

The fundamental picture carries its own contradictions. EV/EBITDA runs near 29x on the snapshot data — down about 9 points over the past 30 days as the EBITDA denominator improves, but still elevated for a cyclical semiconductor company. The headline net income figure is negative (reported net loss of roughly $1.6 billion), with a normalised figure of $5.6 billion once restructuring costs are stripped out. The P/B multiple of 4.8x has more than doubled in 30 days. Capital expenditure remains heavy at over $15 billion, consistent with a company still mid-build on its foundry ambitions. Whether the market is pricing a successful foundry build-out or simply repricing a cyclical trough remains the central debate the next earnings cycle — scheduled for July 23 — will have to resolve.

Close peers split sharply on Monday. QCOM fell 11% in a single session while MXL dropped 10%, both posting similar weekly gains to Intel. AMD gave back 2.3% on the day after a 26% weekly surge of its own. The semiconductor space moved fast this week in both directions, and the divergence in day-over-day returns underscores how binary single-session moves have become in this sector. For Intel specifically, the next data point to watch is whether the analyst community begins upgrading ratings — as opposed to just lifting targets — or whether the stock cools back toward the $80–$100 zone where most of the Street's revised estimates cluster.